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Fatty foods plug up arteries in more ways than 
one, according to Mullick et al., on page 373. 
They also trigger the expression of an innate 
immune receptor that makes the arteries more 
fat friendly.
Recent data suggest that the immune receptor 
in question, Toll-like receptor (TLR) 2, which 
recognizes bacterial lipids, might also enhance 
atherosclerosis—a disease that can lead to restricted 
blood flow due to the accumulation of fat in 
blood vessels. Mice that are plaque prone because 
they cannot properly dispose of fat stay plaque 
free if TLR2 is knocked out. Its loss from im-
mune cells alone, however, does not protect these 
mice, suggesting that TLR2 on a nonimmune cell 
favors plaque growth. 
Mullick et al. now find that TLR2 is expressed 
on the endothelial cells that line the curves of 
blood vessels. These cells are plaque prone by 
nature; the uneven blood flow here stimulates 
them to express more adhesion molecules and 
chemokines. They thus attract both circulating fat 
and macrophages that eat 
the fat and then harden 
into plaques. A high-fat 
diet thus increases plaque 
formation in part by giv-
ing macrophages more to 
chew on.
A high-fat diet also in-
creased endothelial TLR2 
levels in the atherosclerosis-
prone mice, the authors 
found. Components of di-
etary fat may bind to TLR2 
and thereby increase ex-
pression of the receptor on 
endothelial cells. These mice 
accumulated larger fat deposits and more macro-
phages in vessel curves than did their TLR2-
deficient counterparts. The team has yet to 
determine how TLR2 expands plaques. Perhaps, 
like uneven blood flow, it increases endothelial 
cell adhesion molecule or chemokine levels. 
Unmasking an inflammatory suppressor
Mice that tend to overreact to infection appear to have a failsafe mechanism that kicks in before 
inflammation gets out of control, say Conner et al. (page 305). Oddly enough, the dampener was known 
for its ability to enhance inflammation.
To find genes that unleash uncontrolled inflammation and pathways that inhibit them, the authors turned 
to mice whose cells overreact to inflammatory stimuli that trigger Toll-like receptors (TLRs). The mice, however, 
do not suffer ill effects from their overzealous response. One potential explanation, the authors reasoned, 
is that mutations in TLR response genes might be counterbalanced by mutations in regulatory genes.
The group has now mapped the phenotype of these mice to two loci. The first locus contained the gene for 
the interleukin receptor–associated kinase (IRAK) 2, which helps turn on inflammatory cytokine genes in 
TLR-activated cells. The second locus contained a gene encoding IRAK1-binding protein (IRAK1BP) 1, which was 
previously identified as an enhancer of some proinflammatory signals.
In cells from the easily inflamed mice, however, IRAK1BP1 
partially suppressed their proinflammatory phenotype. TLR-activated 
macrophages from these mice turned on IRAK1BP1, which then 
suppressed the transcriptional activation of several cytokines. 
Macrophages from normal mouse strains, however, did not 
express IRAK1BP1 in response to TLR activation. The prior study 
suggesting a proinflammatory role for IRAK1BP1 relied on 
overexpression of the protein in a cell line; the role of endogenous 
IRAK1BP1 had not been explored.
The team found several differences between the IRAK1BP1 
promoter sequence in normal and hyperreactive mice. But whether 
these differences determine the alternative expression of IRAK1BP1 
is not clear. In normal mice, IRAK1BP1 might only kick in when other 
inflammation-suppressing mechanisms go awry. 
Mice that tend to have vigorous inflammatory responses (right) 
compensate by expressing the antiinflammatory gene IRAK1BP1.
A high fat diet increases the expression of 
Toll-like receptor 2 (green) on endothelial cells 
within four weeks (left to right).
C
O
U
R
T
E
S
Y
 
O
F
 
P
.
 
B
R
O
D
E
U
R
Toll signals provoke plaque buildup